Lena Specht

Professor of Oncology

University of Copenhagen

Denmark

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Lena Specht is a renowned faculty member at the University of Copenhagen, Denmark. Her research primarily focuses on oncology, examining topics such as late cardiac toxicity following cancer treatments, radiation therapy patterns, and risk stratification in head and neck cancer. Additionally, she investigates personalized therapy approaches in follicular lymphoma and the long-term effects of hematopoietic stem cell transplantation in pediatric patients.

Articles (18)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (18)

Jamie Flerlage

Division Chief Pediatric Hematology/Oncology

University of Rochester Medical Center

UNITED STATES

Lena Specht

Research Interests

Contact this professor

About

Articles (18)

Risk Stratification for Trial Enrichment Considering Loco‐Regional Failure in Head and Neck Cancer: UICC8 Versus Purpose‐Built Failure‐Type Specific Risk Prediction Model

Late Cardiac Toxicity After Anthracyclines and Radiotherapy for Lymphoma—A Regression Analysis of Dose‐Response

International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma

Real-World Pattern-of-Care Analysis of Primary Cutaneous Lymphomas Radiation Therapy Among European Organisation for Research and Treatment of Cancer Members

Late effects following HSCT for childhood ALL

Long-Term Follow-Up of the Response-Adapted Intergroup EORTC/LYSA/FIL H10 Trial for Localized Hodgkin Lymphoma

Primary central nervous system lymphomas

Primary central nervous system lymphomas

A systematic review on clinical adaptive radiotherapy for head and neck cancer

The potential for local ablative therapy of oligometastases in head and neck squamous cell carcinoma: a real-world data analysis

Personalised therapy in follicular lymphoma – is the dial turning?

Career development: A balance of opportunities and choices

Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial

Cardiovascular risk factors, radiation therapy, and myocardial infarction among lymphoma survivors

Patterns of relapse and long-term outcome in patients treated with a curative intent for advanced Hodgkin lymphoma

Long-term Safety of Treatment with Autologous Mesenchymal Stem Cells in Patients with Radiation-Induced Xerostomia: Primary Results of the MESRIX Phase I/II Randomized Trial

Intraglandular Off-the-Shelf Allogeneic Mesenchymal Stem Cell Treatment in Patients with Radiation-Induced Xerostomia: A Safety Study (MESRIX-II)

Baseline FDG PET/CT in free breathing versus deep inspiration breath-hold for pediatric patients with mediastinal lymphoma

Collaborators (18)

Jamie Flerlage

Anita Gothelf

Chan Yoon Cheah

Daphne de Jong

Jann Mortensen

Christine Smith

Maja Vestmø Maraldo

Siri Beier Jensen

Jeppe Friborg

Matthew Matasar

Eva Kimby

Eliza Hawkes

Adam Espe Hansen

Gitte Bjørnsen Fredberg Persson

Olivier Casasnovas

Gry Hoffmann Barfod

Bartlomiej Tomasik

Ajay Major

Make your next move.